APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phosphate Buffered Saline (PBS) Tablet

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Phosphate Buffered Saline (PBS) Tablet Market Analysis and Forecast 2026-2032

5 July 2026171 pages

Choose your research edition.

Industry ResearchPhosphate Buffered Saline (PBS) Tablet Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Phosphate Buffered Saline (PBS) Tablet Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Phosphate Buffered Saline (PBS) Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phosphate Buffered Saline (PBS) Tablet Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Phosphate Buffered Saline (PBS) Tablet Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Phosphate Buffered Saline (PBS) Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Phosphate Buffered Saline (PBS) Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Phosphate Buffered Saline (PBS) Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Phosphate Buffered Saline (PBS) Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Phosphate Buffered Saline (PBS) Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Phosphate Buffered Saline (PBS) Tablet include Merck, Valiant, Tocris Bioscience, Thermo Fisher, Takara Bio, Spectrum Chemical, R-Biopharm AG, R&D Systems and Novus Biologicals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Phosphate Buffered Saline (PBS) Tablet, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Phosphate Buffered Saline (PBS) Tablet, also provides the revenue of main regions and countries. Of the upcoming market potential for Phosphate Buffered Saline (PBS) Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Phosphate Buffered Saline (PBS) Tablet revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Phosphate Buffered Saline (PBS) Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Phosphate Buffered Saline (PBS) Tablet revenue, projected growth trends, production technology, application and end-user industry.

Phosphate Buffered Saline (PBS) Tablet Segment by Company

Merck

Valiant

Tocris Bioscience

Thermo Fisher

Takara Bio

Spectrum Chemical

R-Biopharm AG

R&D Systems

Novus Biologicals

MyBioSource

Medicago AB

Bio Basic

Phosphate Buffered Saline (PBS) Tablet Segment by Type

Soluble in 500ML Water

Soluble in 200ML Water

Soluble in 100ML Water

Others

Phosphate Buffered Saline (PBS) Tablet Segment by Application

University Laboratory

Business Research Institute

Others

Phosphate Buffered Saline (PBS) Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphate Buffered Saline (PBS) Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phosphate Buffered Saline (PBS) Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphate Buffered Saline (PBS) Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Phosphate Buffered Saline (PBS) Tablet in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Phosphate Buffered Saline (PBS) Tablet company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phosphate Buffered Saline (PBS) Tablet revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Phosphate Buffered Saline (PBS) Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Soluble in 500ML Water Major Player Table 3. Soluble in 200ML Water Major Player Table 4. Soluble in 100ML Water Major Player Table 5. Others Major Player Table 6. Global Phosphate Buffered Saline (PBS) Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. University Laboratory Major Player Table 8. Business Research Institute Major Player Table 9. Others Major Player Table 10. Phosphate Buffered Saline (PBS) Tablet Industry Trends Table 11. Phosphate Buffered Saline (PBS) Tablet Industry Drivers Table 12. Phosphate Buffered Saline (PBS) Tablet Industry Opportunities and Challenges Table 13. Phosphate Buffered Saline (PBS) Tablet Industry Restraints Table 14. Global Phosphate Buffered Saline (PBS) Tablet Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Phosphate Buffered Saline (PBS) Tablet Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Phosphate Buffered Saline (PBS) Tablet Market Share by Region (2021-2026) Table 17. Global Phosphate Buffered Saline (PBS) Tablet Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Phosphate Buffered Saline (PBS) Tablet Market Share by Region (2027-2032) Table 19. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Players (2021-2026) Table 21. Global Phosphate Buffered Saline (PBS) Tablet Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Phosphate Buffered Saline (PBS) Tablet Key Players Headquarters & Area Served Table 23. Global Phosphate Buffered Saline (PBS) Tablet Players, Product Type & Application Table 24. Global Phosphate Buffered Saline (PBS) Tablet Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Phosphate Buffered Saline (PBS) Tablet by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Type (2021-2026) Table 31. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Type (2027-2032) Table 32. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Application (2021-2026) Table 36. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Application (2027-2032) Table 37. Merck Company Information Table 38. Merck Business Overview Table 39. Merck Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Merck Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 41. Merck Recent Development Table 42. Valiant Company Information Table 43. Valiant Business Overview Table 44. Valiant Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Valiant Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 46. Valiant Recent Development Table 47. Tocris Bioscience Company Information Table 48. Tocris Bioscience Business Overview Table 49. Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 51. Tocris Bioscience Recent Development Table 52. Thermo Fisher Company Information Table 53. Thermo Fisher Business Overview Table 54. Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 56. Thermo Fisher Recent Development Table 57. Takara Bio Company Information Table 58. Takara Bio Business Overview Table 59. Takara Bio Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Takara Bio Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 61. Takara Bio Recent Development Table 62. Spectrum Chemical Company Information Table 63. Spectrum Chemical Business Overview Table 64. Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 66. Spectrum Chemical Recent Development Table 67. R-Biopharm AG Company Information Table 68. R-Biopharm AG Business Overview Table 69. R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 71. R-Biopharm AG Recent Development Table 72. R&D Systems Company Information Table 73. R&D Systems Business Overview Table 74. R&D Systems Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. R&D Systems Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 76. R&D Systems Recent Development Table 77. Novus Biologicals Company Information Table 78. Novus Biologicals Business Overview Table 79. Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 81. Novus Biologicals Recent Development Table 82. MyBioSource Company Information Table 83. MyBioSource Business Overview Table 84. MyBioSource Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. MyBioSource Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 86. MyBioSource Recent Development Table 87. Medicago AB Company Information Table 88. Medicago AB Business Overview Table 89. Medicago AB Phosphate Buffered Saline (PBS) Tablet Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Medicago AB Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 91. Medicago AB Recent Development Table 92. Bio Basic Company Information Table 93. Bio Basic Business Overview Table 94. Bio Basic Phosphate Buffered Saline (PBS) Tablet Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Bio Basic Phosphate Buffered Saline (PBS) Tablet Product Portfolio Table 96. Bio Basic Recent Development Table 97. North America Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021-2026) & (US$ Million) Table 103. North America Phosphate Buffered Saline (PBS) Tablet Revenue by Country (US$ Million) & (2027-2032) Table 104. Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021-2026) & (US$ Million) Table 110. Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Country (US$ Million) & (2027-2032) Table 111. China Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026) & (US$ Million) Table 112. China Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032) & (US$ Million) Table 113. China Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026) & (US$ Million) Table 114. China Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026) & (US$ Million) Table 116. Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032) & (US$ Million) Table 117. Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026) & (US$ Million) Table 118. Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Region (US$ Million) & (2021-2026) Table 121. Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Region (US$ Million) & (2027-2032) Table 122. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026) & (US$ Million) Table 123. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032) & (US$ Million) Table 124. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026) & (US$ Million) Table 125. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032) & (US$ Million) Table 126. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021-2026) & (US$ Million) Table 128. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Country (US$ Million) & (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Phosphate Buffered Saline (PBS) Tablet Image Figure 2. Global Phosphate Buffered Saline (PBS) Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phosphate Buffered Saline (PBS) Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 4. Soluble in 500ML Water Image Figure 5. Soluble in 200ML Water Image Figure 6. Soluble in 100ML Water Image Figure 7. Others Image Figure 8. Global Phosphate Buffered Saline (PBS) Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Phosphate Buffered Saline (PBS) Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 10. University Laboratory Image Figure 11. Business Research Institute Image Figure 12. Others Image Figure 13. Global Phosphate Buffered Saline (PBS) Tablet Market Size (US$ Million) & (2021-2032) Figure 14. Global Phosphate Buffered Saline (PBS) Tablet Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Phosphate Buffered Saline (PBS) Tablet Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Phosphate Buffered Saline (PBS) Tablet Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Type (2021-2032) Figure 21. Global Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Application (2021-2032) Figure 24. North America Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032) Figure 26. North America Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032) Figure 27. North America Phosphate Buffered Saline (PBS) Tablet Revenue Share by Country (2021-2032) Figure 28. United States Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032) Figure 33. Europe Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032) Figure 34. Europe Phosphate Buffered Saline (PBS) Tablet Revenue Share by Country (2021-2032) Figure 35. Germany Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032) Figure 45. China Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032) Figure 46. Asia Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032) Figure 48. Asia Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032) Figure 49. Asia Phosphate Buffered Saline (PBS) Tablet Revenue Share by Region (2021-2032) Figure 50. Japan Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032) Figure 58. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032) Figure 59. SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue Share by Country (2021-2032) Figure 60. Brazil Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Phosphate Buffered Saline (PBS) Tablet Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Soluble in 500ML Water
  • Soluble in 200ML Water
  • Soluble in 100ML Water
  • Others
Applications
  • University Laboratory
  • Business Research Institute
  • Others
Companies covered
  • Merck
  • Valiant
  • Tocris Bioscience
  • Thermo Fisher
  • Takara Bio
  • Spectrum Chemical
  • R-Biopharm AG
  • R&D Systems
  • Novus Biologicals
  • MyBioSource
  • Medicago AB
  • Bio Basic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Phosphate Buffered Saline (PBS) Tablet Market by Type
  3. 1.2.1 Global Phosphate Buffered Saline (PBS) Tablet Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Soluble in 500ML Water
  5. 1.2.3 Soluble in 200ML Water
  6. 1.2.4 Soluble in 100ML Water
  7. 1.2.5 Others
  8. 1.3 Phosphate Buffered Saline (PBS) Tablet Market by Application
  9. 1.3.1 Global Phosphate Buffered Saline (PBS) Tablet Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 University Laboratory
  11. 1.3.3 Business Research Institute
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Phosphate Buffered Saline (PBS) Tablet Market Dynamics
  1. 2.1 Phosphate Buffered Saline (PBS) Tablet Industry Trends
  2. 2.2 Phosphate Buffered Saline (PBS) Tablet Industry Drivers
  3. 2.3 Phosphate Buffered Saline (PBS) Tablet Industry Opportunities and Challenges
  4. 2.4 Phosphate Buffered Saline (PBS) Tablet Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Phosphate Buffered Saline (PBS) Tablet Market Perspective (2021-2032)
  2. 3.2 Global Phosphate Buffered Saline (PBS) Tablet Growth Trends by Region
  3. 3.2.1 Global Phosphate Buffered Saline (PBS) Tablet Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Phosphate Buffered Saline (PBS) Tablet Market Size by Region (2021-2026)
  5. 3.2.3 Global Phosphate Buffered Saline (PBS) Tablet Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Players
  2. 4.1.1 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Players (2021-2026)
  3. 4.1.2 Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Phosphate Buffered Saline (PBS) Tablet Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Phosphate Buffered Saline (PBS) Tablet Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Phosphate Buffered Saline (PBS) Tablet Key Players Headquarters & Area Served
  7. 4.4 Global Phosphate Buffered Saline (PBS) Tablet Players, Product Type & Application
  8. 4.5 Global Phosphate Buffered Saline (PBS) Tablet Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Phosphate Buffered Saline (PBS) Tablet Market CR5 and HHI
  11. 4.6.3 2025 Phosphate Buffered Saline (PBS) Tablet Tier 1, Tier 2, and Tier 3
5 Phosphate Buffered Saline (PBS) Tablet Market Size by Type
  1. 5.1 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2032)
  3. 5.3 Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Type (2021-2032)
6 Phosphate Buffered Saline (PBS) Tablet Market Size by Application
  1. 6.1 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2032)
  3. 6.3 Global Phosphate Buffered Saline (PBS) Tablet Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Valiant
  8. 7.2.1 Valiant Company Information
  9. 7.2.2 Valiant Business Overview
  10. 7.2.3 Valiant Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Valiant Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  12. 7.2.5 Valiant Recent Developments
  13. 7.3 Tocris Bioscience
  14. 7.3.1 Tocris Bioscience Company Information
  15. 7.3.2 Tocris Bioscience Business Overview
  16. 7.3.3 Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Tocris Bioscience Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  18. 7.3.5 Tocris Bioscience Recent Developments
  19. 7.4 Thermo Fisher
  20. 7.4.1 Thermo Fisher Company Information
  21. 7.4.2 Thermo Fisher Business Overview
  22. 7.4.3 Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  24. 7.4.5 Thermo Fisher Recent Developments
  25. 7.5 Takara Bio
  26. 7.5.1 Takara Bio Company Information
  27. 7.5.2 Takara Bio Business Overview
  28. 7.5.3 Takara Bio Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Takara Bio Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  30. 7.5.5 Takara Bio Recent Developments
  31. 7.6 Spectrum Chemical
  32. 7.6.1 Spectrum Chemical Company Information
  33. 7.6.2 Spectrum Chemical Business Overview
  34. 7.6.3 Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Spectrum Chemical Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  36. 7.6.5 Spectrum Chemical Recent Developments
  37. 7.7 R-Biopharm AG
  38. 7.7.1 R-Biopharm AG Company Information
  39. 7.7.2 R-Biopharm AG Business Overview
  40. 7.7.3 R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  41. 7.7.4 R-Biopharm AG Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  42. 7.7.5 R-Biopharm AG Recent Developments
  43. 7.8 R&D Systems
  44. 7.8.1 R&D Systems Company Information
  45. 7.8.2 R&D Systems Business Overview
  46. 7.8.3 R&D Systems Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  47. 7.8.4 R&D Systems Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  48. 7.8.5 R&D Systems Recent Developments
  49. 7.9 Novus Biologicals
  50. 7.9.1 Novus Biologicals Company Information
  51. 7.9.2 Novus Biologicals Business Overview
  52. 7.9.3 Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Novus Biologicals Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  54. 7.9.5 Novus Biologicals Recent Developments
  55. 7.10 MyBioSource
  56. 7.10.1 MyBioSource Company Information
  57. 7.10.2 MyBioSource Business Overview
  58. 7.10.3 MyBioSource Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MyBioSource Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  60. 7.10.5 MyBioSource Recent Developments
  61. 7.11 Medicago AB
  62. 7.11.1 Medicago AB Company Information
  63. 7.11.2 Medicago AB Business Overview
  64. 7.11.3 Medicago AB Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Medicago AB Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  66. 7.11.5 Medicago AB Recent Developments
  67. 7.12 Bio Basic
  68. 7.12.1 Bio Basic Company Information
  69. 7.12.2 Bio Basic Business Overview
  70. 7.12.3 Bio Basic Phosphate Buffered Saline (PBS) Tablet Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bio Basic Phosphate Buffered Saline (PBS) Tablet Product Portfolio
  72. 7.12.5 Bio Basic Recent Developments
8 North America
  1. 8.1 North America Phosphate Buffered Saline (PBS) Tablet Revenue (2021-2032)
  2. 8.2 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2032)
  3. 8.2.1 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026)
  4. 8.2.2 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032)
  5. 8.3 North America Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032)
  6. 8.4 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2032)
  7. 8.4.1 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026)
  8. 8.4.2 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032)
  9. 8.5 North America Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032)
  10. 8.6 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Country
  11. 8.6.1 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021-2026)
  13. 8.6.3 North America Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Phosphate Buffered Saline (PBS) Tablet Revenue (2021-2032)
  2. 9.2 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2032)
  3. 9.2.1 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026)
  4. 9.2.2 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032)
  5. 9.3 Europe Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032)
  6. 9.4 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2032)
  7. 9.4.1 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026)
  8. 9.4.2 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032)
  9. 9.5 Europe Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032)
  10. 9.6 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Country
  11. 9.6.1 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021-2026)
  13. 9.6.3 Europe Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Phosphate Buffered Saline (PBS) Tablet Revenue (2021-2032)
  2. 10.2 China Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2032)
  3. 10.2.1 China Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026)
  4. 10.2.2 China Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032)
  5. 10.3 China Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032)
  6. 10.4 China Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2032)
  7. 10.4.1 China Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026)
  8. 10.4.2 China Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032)
  9. 10.5 China Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Phosphate Buffered Saline (PBS) Tablet Revenue (2021-2032)
  2. 11.2 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2032)
  3. 11.2.1 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026)
  4. 11.2.2 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032)
  5. 11.3 Asia Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032)
  6. 11.4 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2032)
  7. 11.4.1 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026)
  8. 11.4.2 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032)
  9. 11.5 Asia Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032)
  10. 11.6 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Country
  11. 11.6.1 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021-2026)
  13. 11.6.3 Asia Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue (2021-2032)
  2. 12.2 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Type (2027-2032)
  5. 12.3 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Application (2027-2032)
  9. 12.5 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Country
  11. 12.6.1 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Phosphate Buffered Saline (PBS) Tablet Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst